Sepsis Syndrome Clinical Trial
Official title:
Platelet Reactivity During Different Stages of Sepsis
Activation of blood platelets is a typical finding in patients with systemic inflammation and sepsis.They seem to mediate key pro-inflammatory mediator secretion, immune-cell activation while their adhesion to the endothelium enhances the pro-coagulatory activity of endothelial cells impairing microcirculation thus, may lead to multiple organ dysfunction. However, the exact effects of bacterial products on platelet function have not been found to be consistent and may vary according to the species, the timing of the study, and the pathogenesis of sepsis. Data vary, including both increased and decreased platelet reactivity and aggregation among patients with sepsis compared to healthy controls. Defining platelet's behaviour during sepsis is particularly important in view of recent findings revealing potential association between antiplatelet therapy and reduction in short term mortality, incidence of acute lung injury and intensive care unit admission in critically ill patients.This study aims to measure P2Y12 mediated platelet reactivity, -using the point-of-care P2Y12 VerifyNow assay, in platelet reactivity units (PRU)- along different stages of sepsis, including bacteremia/uncomplicated infection, sepsis, severe sepsis and septic shock. Subgroup follow up of patients going along different stages will also be performed. At the end of this study analysis of clinical and laboratory findings in correlation with platelet reactivity will be performed to assess platelet aggregation during sepsis.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Not yet recruiting |
NCT04560842 -
The Efficacy of High-flow Nasal Cannula Oxygen Therapy in Sepsis Patients
|
N/A | |
| Completed |
NCT04475081 -
Use of a Live Attenuated Vaccine as an Immune-based Preventive Against COVID-19-associated Sepsis
|
Phase 3 | |
| Completed |
NCT03314831 -
The Role of Myristic Acid in Serum for Early Diagnosis of Sepsis and Comparison With Selected Biomarkers of Sepsis
|
||
| Completed |
NCT03371680 -
Kinetics of Surfactant Proteins, Phosphatidylcholine and Body Water in Intensive Care Unit (ICU)
|
N/A | |
| Completed |
NCT00046072 -
A Safety and Efficacy Study of Intravenous E5564 in Patients With Severe Sepsis
|
Phase 2 | |
| Enrolling by invitation |
NCT05602584 -
Effect of Immunophenotype on Prognosis of Sepsis
|
||
| Completed |
NCT06338111 -
Interventions Meant to Improve the Outcome of Critical Care Patients in the ED
|
||
| Completed |
NCT04292431 -
Leukocyte MOrphology and CORticosteroids Response in SEPtic Patients (MOCORSEP)
|
||
| Recruiting |
NCT03472170 -
Clinical Trial for Valuation of the Effectiveness of Lactoferrine in the Prevention of Sepsis in New Premature Born. Bimonitorization of the Antinflammatory Mechanisms, Antioxidants and the Intestinal Microbiote.
|
N/A | |
| Not yet recruiting |
NCT05382078 -
Nafamostat Mesilate for Anticoagulation During CRRT in Critically Ill Patients
|
||
| Recruiting |
NCT03956043 -
Diagnostic Accuracy in Sepsis
|
||
| Recruiting |
NCT05977153 -
CT for Personalized Mechanical Ventilation
|
N/A | |
| Completed |
NCT00448968 -
The Utility of Ischemia Modified Albumin (IMA) in Sepsis
|
N/A | |
| Completed |
NCT05246969 -
Detecting Sepsis in Patients With Severe Subarachnoideal Hemorrhage
|
||
| Recruiting |
NCT05261607 -
Analysis of the Evolution of Mortality in an Intensive Care Unit
|
||
| Recruiting |
NCT04203979 -
Sepsis: From Syndrome to Personalized Care
|
||
| Recruiting |
NCT03990467 -
Observed Pharmacokinetic of Piperacillin/Tazobactam Compared to Amikacin in ICU
|
N/A | |
| Recruiting |
NCT05338359 -
Metrology to Enable Rapid and Accurate Clinical Measurements in Acute Management of Sepsis
|
||
| Active, not recruiting |
NCT02643121 -
Utility of Presepsin in Children Sepsis
|
N/A | |
| Completed |
NCT00142220 -
The Benefit of Adding Fish Oil to the Nutrition of Critically Ill Patients
|
Phase 4 |